This review summarizes the roles of CD4+T and CD8+T cells in fibrotic diseases such as IPF and silicosis, as well as related therapeutic strategies, with a view to providing new perspectives for understanding the pathogenesis of pulmonary fibrosis and developing therapeutic strategies targeting specific T cell types. This evidence concerns the gene CD4 and idiopathic pulmonary fibrosis.